Vera Therapeutics (VERA) Other Non-Current Liabilities (2020 - 2026)

Vera Therapeutics (VERA) has 2 years of Other Non-Current Liabilities data on file, last reported at $1.9 million in Q1 2026.

• Quarterly Other Non-Current Liabilities changed N/A year-over-year to $1.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.9 million (changed N/A YoY) and the FY2025 annual result came in at $1.9 million, changed N/A from the prior year.
• Other Non-Current Liabilities fell to $1.9 million in Q1 2026, from $1.9 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $1.9 million in Q4 2025 to a low of $1.9 million in Q1 2026.